These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5881 related articles for article (PubMed ID: 23872180)

  • 21. PEG-detachable lipid-polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells.
    Du JB; Song YF; Ye WL; Cheng Y; Cui H; Liu DZ; Liu M; Zhang BL; Zhou SY
    Anticancer Drugs; 2014 Aug; 25(7):751-66. PubMed ID: 24590167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolyplexes comprising imidazole/imidazolium lipophosphoramidate, histidinylated polyethyleneimine and siRNA as efficient formulation for siRNA transfection.
    Gonçalves C; Berchel M; Gosselin MP; Malard V; Cheradame H; Jaffrès PA; Guégan P; Pichon C; Midoux P
    Int J Pharm; 2014 Jan; 460(1-2):264-72. PubMed ID: 24225347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes.
    Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y
    Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylated phospholipid membrane on polymer cushion and its interaction with cholesterol.
    Zhang Y; Chen Y; Jin G
    Langmuir; 2010 Jul; 26(13):11140-4. PubMed ID: 20415472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
    Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E
    Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
    Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
    Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating.
    Oumzil K; Khiati S; Grinstaff MW; Barthélémy P
    J Control Release; 2011 Apr; 151(2):123-30. PubMed ID: 21354443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
    Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
    Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B; Zhang H; Yu L
    Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids.
    Thevenot J; Troutier AL; David L; Delair T; Ladavière C
    Biomacromolecules; 2007 Nov; 8(11):3651-60. PubMed ID: 17958441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
    J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma.
    Kaffashi A; Lüle S; Bozdağ Pehlivan S; Sarısözen C; Vural İ; Koşucu H; Demir T; Buğdaycı KE; Söylemezoğlu F; Karlı Oğuz K; Mut M
    J Pharm Pharmacol; 2017 Aug; 69(8):1010-1021. PubMed ID: 28471040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
    Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.
    Tahir N; Madni A; Correia A; Rehman M; Balasubramanian V; Khan MM; Santos HA
    Int J Nanomedicine; 2019; 14():4961-4974. PubMed ID: 31308666
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
    Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
    J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
    Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
    Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 295.